Destiny Wealth Partners’s Eli Lilly LLY Stock Holding History

Destiny Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,276	Closed	-$1.17M	–	686
2026 Q1	$1.17M	Buy	1,276 +479	+60%	+$486K	0.13%	91
2025 Q4	$847K	Hold	797	–	–	0.1%	99
2025 Q3	$608K	Sell	797 -4	-0.5%	-$2.98K	0.07%	115
2025 Q2	$624K	Buy	+801	New	+$622K	0.08%	105
2023 Q1	–	Sell	-91	Closed	-$33.3K	–	431
2022 Q4	$33.3K	Buy	91 +45	+98%	+$16K	0.01%	339
2022 Q3	$15K	Hold	46	–	–	﹤0.01%	386
2022 Q2	$15K	Sell	46 -297	-87%	-$89.2K	﹤0.01%	390
2022 Q1	$98K	Buy	343 +319	+1,329%	+$82.1K	0.02%	248
2021 Q4	$7K	Hold	24	–	–	﹤0.01%	466
2021 Q3	$6K	Buy	+24	New	+$5.92K	﹤0.01%	448
2021 Q2	–	Sell	-267	Closed	-$50K	–	362
2021 Q1	$50K	Sell	267 -1,628	-86%	-$318K	0.01%	266
2020 Q4	$320K	Buy	+1,895	New	+$283K	0.07%	141

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Destiny Wealth Partners's LLY Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,276 shares — an estimated $1.17M sold.

Destiny Wealth Partners first reported a position in LLY in Q4 2020 and held it in 12 quarters. The position peaked at $1.17M in Q1 2026. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Destiny Wealth Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 1,276 Eli Lilly shares in Q2 2026, an estimated $1.17M.
Destiny Wealth Partners first reported a position in Eli Lilly in Q4 2020 and held it in 12 quarters.
Destiny Wealth Partners's Eli Lilly position peaked at $1.17M in Q1 2026.
4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.